These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28662299)

  • 1. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
    Kato M; Hisada R; Atsumi T
    Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.
    Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
    Br J Haematol; 2013 Jun; 161(5):706-714. PubMed ID: 23530551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
    Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study.
    Les I; Parraza N; Anaut P; Eguiluz S; Sánchez C; Preciado ME; Loza JÁ; Andía A
    Rheumatol Int; 2018 Feb; 38(2):229-238. PubMed ID: 29124399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia in high-risk patients with antiphospholipid syndrome.
    Pontara E; Banzato A; Bison E; Cattini MG; Baroni G; Denas G; Calligaro A; Marson P; Tison T; Ruffatti A; Pengo V
    J Thromb Haemost; 2018 Mar; 16(3):529-532. PubMed ID: 29316193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study.
    Pablo RD; Cacho PM; López-Hoyos M; Calvo-Río V; Riancho-Zarrabeitia L; Martínez-Taboada VM
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):354-362. PubMed ID: 34216367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.
    Yelnik CM; Urbanski G; Drumez E; Sobanski V; Maillard H; Lanteri A; Morell-Dubois S; Caron C; Dubucquoi S; Launay D; Duhamel A; Hachulla E; Hatron PY; Lambert M
    Lupus; 2017 Feb; 26(2):163-169. PubMed ID: 27432808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome.
    Hoy CK; NaveenKumar SK; Navaz SA; Sugur K; Yalavarthi S; Sarosh C; Smith T; Kmetova K; Chong E; Peters NF; Rysenga CE; Norman GL; Figueroa-Parra G; Nelson D; Girard J; Ahmed AZ; Schaefer JK; Gudjonsson JE; Kahlenberg JM; Madison JA; Knight JS; Crowson CS; Duarte-García A; Zuo Y
    Arthritis Rheumatol; 2024 Jun; 76(6):928-935. PubMed ID: 38225923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.
    Barbati C; Stefanini L; Colasanti T; Cipriano E; Celia A; Gabriele G; Vomero M; Ceccarelli F; Spinelli FR; Finucci A; Speziali M; Orso G; Margiotta DPE; Conti F; Violi F; Afeltra A; Valesini G; Alessandri C
    Arthritis Res Ther; 2019 Jul; 21(1):161. PubMed ID: 31262358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review.
    Lambert M; Brodovitch A; Mège JL; Bertin D; Bardin N
    Autoimmun Rev; 2024 Jun; 23(6):103585. PubMed ID: 39094811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.
    Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S
    Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β
    Serrano M; Martínez-Flores JA; Pérez D; García F; Cabrera-Marante O; Pleguezuelo D; Paz-Artal E; Morales JM; González E; Serrano A
    Circulation; 2017 May; 135(20):1922-1934. PubMed ID: 28249878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores.
    Oku K; Amengual O; Yasuda S; Atsumi T
    Curr Rheumatol Rep; 2017 Aug; 19(8):51. PubMed ID: 28741233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.